Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron

Literals

bibo:doi
- 10.1002/cpt.598
ou:bibtex
- @article{Agundez2017,title = {Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron},journal = {Clinical Pharmacology and Therapeutics},year = {2017},author = {Bell, G. and Caudle, K. and Whirl-Carrillo, M. and Gordon, R. and Hikino, H. and Prows, C. and Gaedigk, A. and Agundez, J. and Sadhasivam, S. and Klein, T. and Schwab, M.}}
fabio:hasPublicationYear
- 2017
vcard:url
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017456977&origin=inward
dcterms:publisher
- Clinical Pharmacology and Therapeutics
ou:eid
- 2-s2.0-85017456977
bibo:issn
- 0009-9236
dcterms:title
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron
ou:tipoPublicacion
- Article
dcterms:contributor
- Bell G.C. et al.
dcterms:creator
- Bell G.C.
bibo:page_range
- 213-218
bibo:eissn
- 1532-6535
vivo:identifier
- 2017-787
ou:urlOrcid
- http://www.scopus.com/inward/record.url?eid=2-s2.0-85017456977&partnerID=MN8TOARS
ou:urlScopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85017456977&origin=inward
bibo:volume
- 102